Biotechnology
Sort by: Featured Most recent Most read Most commented
75 results total, viewing 21 - 30
Med-tech companies eager to help each other
Connectivity, collaboration and opportunity: These are the watchwords of industry leaders from the Rhode Island medical-technology community who are organizing a new statewide cluster. more
By Richard Asinof
Contributing Writer | 2/4/13
Covidien’s profits drop slightly in 1Q as sales rise 5%
Medical technology maker Covidien PLC reported first-quarter earnings of $493 million, or $1.03 per diluted share, a slight decrease from the $494 million, or $1.02 per diluted share, reported for the first-quarter of its fiscal 2012. more
| 1/25/13
Amgen tops profit estimates on sales of arthritis, bone drugs
Amgen Inc., one of the world’s largest biotechnology companies, reported fourth-quarter profit that beat analyst estimates as sales of arthritis and bone drugs rose. more
Amgen plans $200 million facility in Singapore
Amgen Inc., one of the world’s largest biotechnology companies, plans to invest $200 million on a new manufacturing facility in Singapore. more
Cumberland pharma firm moves to new office, lab in Mass.
Pharmaceutical developer Collegium Pharmaceutical Inc. has moved its operations out of Cumberland to more refined labs Canton, Mass., the company announced Thursday. more
R.I. medical tech industry building community
On Wednesday evening, Stephen Lane - chairman, chief venture officer and co-founder of Ximedica - played host to a diverse group of more than 40 members of Rhode Island's emerging med-tech community to discuss strategies to enhance connectivity and collaboration. more
Biomedical Structures announces facility expansion, new VP
Biomedical Structures LLC, a developer of biomedical textiles for medical devices, has expanded its medical textile development and manufacturing facilities and appointed a new vice president of research and development, the company announced Tuesday. more
| 1/8/13
Amgen reaches deal to use Bind’s technology to seek cancer drugs
Amgen Inc., one of the world’s biggest biotechnology companies, will spend as much as $180.5 million for the right to develop cancer drugs using nanotechnology from closely held Bind Biosciences. more
Natus to acquire Grass Tech group from Astro-Med for $18.6M
San Carlos, Calif.-based Natus Medical Inc. has entered into a definitive agreement to acquire the Grass Technologies product group from technology manufacturer Astro-Med Inc. for $18.6 million, the companies announced Monday. more
| 1/7/13
Covidien’s Mallinckrodt lands FDA approval for ADHD drug
Mallinckrodt, the pharmaceuticals business of biotechnology giant Covidien PLC, has received approval from the U.S. Food and Drug Administration to manufacture and market a generic version of its Concerta tablets for the treatment of attention deficit hyperactivity disorder, the company announced Monday. more
| 12/31/12
« Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 … 8 | Next »
Calendar
PBN Hosted
Events

Celebrate RI's many exceptional women at PBN's Business Women Awards luncheon May 30th at the Providence Marriott. Reserve your seat today!
Advertisement
National
Local
Latest News